⌘K

Login Start Free

Home/Filings/5/0000918066-04-000011

5//SEC Filing

GUILFORD PHARMACEUTICALS INC 5

Accession 0000918066-04-000011

CIK 0000918066operating

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 3:44 PM ET

Size

37.2 KB

Accession

0000918066-04-000011

Insider Transaction Report

Form 5

Period: 2003-12-31

GUILFORD PHARMACEUTICALS INCGLFD

JORDAN ANDREW R

EVP, Finance & Administration

Transactions

Other
Common Stock
2003-07-31$5.52/sh+336$1,855→ 49,439 total(indirect: By 401(k))
Other
Common Stock
2003-02-01$3.43/sh+649$2,226→ 47,611 total(indirect: By 401(k))
Other
Common Stock
2003-03-31$3.70/sh+197$729→ 47,808 total(indirect: By 401(k))
Other
Common Stock
2003-05-30$5.58/sh+887$4,949→ 48,695 total(indirect: By 401(k))
Other
Common Stock
2003-12-31$6.78/sh+218$1,478→ 50,872 total(indirect: By 401(k))
Other
Common Stock
2003-11-28$6.89/sh+298$2,053→ 50,654 total(indirect: By 401(k))
Other
Common Stock
2003-10-31$7.32/sh+293$2,145→ 50,356 total(indirect: By 401(k))
Other
Common Stock
2003-12-31$3.84/sh+781$3,001→ 65,545 total
Other
Common Stock
2003-06-30$4.46/sh+408$1,820→ 49,103 total(indirect: By 401(k))
Other
Common Stock
2003-01-31$2.97/sh+470$1,396→ 46,962 total(indirect: By 401(k))
Other
Common Stock
2003-09-30$6.19/sh+206$1,275→ 50,063 total(indirect: By 401(k))
Other
Common Stock
2003-08-29$5.14/sh+418$2,149→ 49,857 total(indirect: By 401(k))
Award
Stock Options (Right to buy)
2003-02-18$2.99/sh+50,000$149,500→ 50,000 total
Exercise: $2.99From: 2004-02-18Exp: 2013-02-18→ Common Stock (50,000 underlying)

Holdings

Common Stock
(indirect: By Children)
150
Stock Options (Right to buy)
Exercise: $8.89From: 2001-09-24Exp: 2011-09-24→ Common Stock (500 underlying)
500
Stock Options (Right to buy)
Exercise: $12.88From: 2000-02-23Exp: 2009-02-23→ Common Stock (30,000 underlying)
30,000
Common Stock
(indirect: By Spouse)
20,589
Stock Options (Right to buy)
Exercise: $17.63From: 1996-12-02Exp: 2006-12-02→ Common Stock (40,000 underlying)
40,000
Stock Options (Right to buy)
Exercise: $14.92From: 1996-02-23Exp: 2006-02-23→ Common Stock (41,250 underlying)
41,250
Stock Options (Right to buy)
Exercise: $8.81From: 2003-02-20Exp: 2012-02-20→ Common Stock (50,000 underlying)
50,000

Footnotes (2)

[F1]1) Shares acquired under Guilford's stock purchase plan.
[F2]1) Shares issued to 401(k) plan account of reporting person as part of company match program; amounts vest in participant accounts 25% per year based on years of service with company.

Documents

1 file

5
c0001206350d20040212f5f.xmlPrimary
PRIMARY DOCUMENT

Issuer

GUILFORD PHARMACEUTICALS INC

CIK 0000918066

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000918066

Filing Metadata

Form type: 5
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 3:44 PM ET
Size: 37.2 KB

View on SEC.gov